Public Health Implications of Bioinformatics

References
1 Butler D. Epidemiology set to get fasttrack treatment. Nature 2001; Nov 8 414 6860 139.
2 Maojo V, Kulikowski CA. Bioinformatics and Medical Informatics: Collaboration on the Road to Genomic Medicine?. J Am Med Inform Assoc. In press. 2003
3 Perera FP, Weinstein IB. Molecular epidemiology: recent advances and future directions. Carcinogenesis 2000; Mar 21 (03) 517-24.
4 Furberg AH, Ambrosone CB. Molecular epidemiology, biomarkers and cancer prevention. Trends Mol Med 2001; Nov 7 (11) 517-21.
5 Lilienfeld AM, Lilienfeld DE. The 1979 Health Clark lectures. ‘The epidemiologic fabric’. I—Weaving the threads. Int J Epidemiol 1980; Sep 9 (03) 199-206.
6 Potter JD. At the interfaces of epidemiology, genetics and genomics. Nat Rev Genet 2001; Feb 2 (02) 142-7.
7 Foxman B, Riley L. Molecular epidemiology: focus on infection. Am J Epidemiol 2001; Jun 15 153 (012) 1135-41.
8 Beskow LM, Khoury MJ, Baker TG, Thrasher JF. The Integration of Genomics into Public Health Research, Policy and Practice in the United States. Community Genet 2001; Jul 4 (01) 2-11.
9 Maojo V, Iakovidis I, Martin-Sanchez F, Crespo J, Kulikowski C. Medical informatics and bioinformatics: European efforts to facilitate synergy. J Biomed Inform 2001; Dec 34 (06) 423-7.
10 Martin-Sanchez F, Maojo V. Lopez-Campos G. Integrating genomics into health information systems. Methods Inf Med 2002; 41 (01) 25-30.
11 Collins FS, McKusick VA. Implications of the Human Genome Project for medical science. JAMA 2001; Feb 7 285 (05) 540-4.
12 Collins FS, Guttmacher AE. Genetics moves into the medical mainstream. JAMA 2001; Nov 14 286 (018) 2322-4.
13 Kohane I. Bioinformatics and Clinical Informatics: The Imperative to Collaborate. J Am Med Inform Assoc 2000; 7 5: 439-443.
14 Kulikowski C. The Micro-Macro Spectrum of Medical Informatics. Challenges: From Molecular Medicine to Transforming Health Care in a Globalizing Society. Methods Inf Med 2001; 41: 20-4.
15 Miller P. Opportunities at the Intersection of Bioinformatics and Health Informatics. J Am Med Inform Assoc 2000; 7 (05) 431-8.
16 Altman R. The Interactions Between Clinical Informatics and Bioinformatics. J Am Med Inform Assoc 2000; 7 (05) 439-43.
17 Henry CJ, Phillips R, Carpanini F, Corton JC, Craig K, Igarashi K. et al. Use of genomics in toxicology and epidemiology: findings and recommendations of a workshop. Environ Health Perspect 2002; Oct 110 (10) 1047-50.
18 Benton D. Bioinformatics—principles and potential of a new multidisciplinary tool. Trends Biotechnol 1996; Aug 14 (08) 261-72.
19 Roberts RJ. The early days of bioinformatics publishing. Bioinformatics 2000; Jan 16 (01) 2-4.
20 Bairoch A. Serendipity in bioinformatics, the tribulations of a Swiss bioinformatician through exciting times. Bioinformatics 2000; Jan 16 (01) 48-64.
21 Mount D. Bioinformatics: Sequence and Genome Analysis. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 2001
22 van Belkum A, Struelens M, de Visser A, Verbrugh H, Tibayrenc M. Role of genomic typing in taxonomy, evolutionary genetics, and microbial epidemiology. Clin Microbiol Rev 2001; Jul 14 (03) 547-60.
23 Dennise D. Dalma-Weiszhausz, Marina E. Chicurel, Thomas R. Gingeras Microarrays and Genetic Epidemiology: A Multipurpose Tool for a Multifaceted Field. Genetic Epidemiology 2002; 23: 4-20.
24 Lander ES. et al. Initial sequencing and analysis of the human genome. Nature 2001; Feb 15 409 6822 860-921.
25 Olden K, Wilson S. Environmental health and genomics: visions and implications. Nat Rev Genet 2000; Nov 1 (02) 149-53.
26 Fauci AS. Infectious diseases: considerations for the 21st century. Clin Infect Dis 2001; Mar 1 32 (05) 675-85.
27 Pang T. The impact of genomics on global health. Am J Public Health 2002; Jul 92 (07) 1077-9.
28 Austin MA. Ethical issues in human genome epidemiology: a case study based on the Japanese American Family Study in Seattle, Washington. Am J Epidemiol 2002; Apr 1 155 (07) 585-92.
29 Annas GJ. Rules for research on human genetic variation—lessons from Iceland. N Engl J Med 2000; Jun 15 342 (24) 1830-3.
30 Cambon-Thomsen A. Assessing the impact of biobanks. Nat Genet 2003; May 34 (01) 25-6.
31 Kaiser J. Biobanks. Population databases boom, from Iceland to the. U.S. Science 2002; Nov 8 298 5596 1158-61.
32 Ellsworth DL, Manolio TA. The Emerging Importance of Genetics in Epidemiologic Research III. Bioinformatics and statistical genetic methods. Ann Epidemiol 1999; May 9 (04) 207-24.
33 Institute of Medicine. The Future of Public Health. Washington, DC: National Academy Press; 1988
34 Steinberg KK, Gwinn M, Khoury MJ. The role of genomics in public health and disease prevention. JAMA 2001; Oct 3 286 (13) 1635.
35 Weatherall D. Science and the Quiet Art. Medical Research & Patient Care. Oxford: Oxford University Press; 1995
36 Noonan AS. Integrating genomics into US public health. Med 2002; Nov-Dec 4 (06) Suppl 68S-71S.
37 Mostowy S, Behr MA. Comparative genomics in the fight against tuberculosis: diagnostics, epidemiology, and BCG vaccination. Am J Pharmacogenomics 2002; 2 (03) 189-96.
38 Schork NJ, Fallin D, Lanchbury JS. Single nucleotide polymorphisms and the future of genetic epidemiology. Clin Genet 2000; Oct 58 (04) 250-64.
39 Hoffman SL. Infectious disease. Research (genomics) is crucial to attacking malaria. Science 2000; Nov 24 290 5496 1509.
40 Bertone P, Gerstein M. Integrative data mining: the new direction in bioinformatics. IEEE Eng Med Biol Mag 2001; Jul-Aug 20 (04) 33-40.
41 Lindberg C. The Unified Medical Language System (UMLS) of the National Library of Medicine. J Am Med Rec Assoc 1990; May 61 (05) 40-2.
42 The Gene Ontology Consortium. Gene Ontology: tool for the unification of biology. Nature Genetics 2000; 25: 25-29.
43 Gilbert GL. Molecular diagnostics in infectious diseases and public health microbiology: cottage industry to postgenomics. Trends Mol Med 2002; Jun 8 (06) 280-7.
44 Broder S, Hoffman SL, Hotez PJ. Cures for the Third World’s problems: the application of genomics to the diseases plaguing the developing world may have huge medical and economic benefits for those countries and might even prevent armed conflict. EMBO Rep 2002; Sep 3 (09) 806-12.
45 Goldie SJ, Levin AR. MSJAMA. Genomics in medicine and public health: role of costeffectiveness analysis. JAMA 2001; Oct 3 286 (13) 1637-8.
46 Visionary experimental designs. Nature 2001; Nov 8 414 6860 133 [No authors listed].
47 Millikan R. The changing face of epidemiology in the genomics era. Epidemiology 2002; Jul 13 (04) 472-80.
48 Maojo V, Martin-Sanchez F, Billhardt H, Iakovidis I, Kulikowski C. Establishing an agenda for biomedical informatics. Methods Inf Med 2003; 42 (02) 121-5.